Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2003
04/01/2003US6541220 Novel parathyroid hormone (PTH), parathyroid hormone related protein (PTHrP), receptors (PTH1R and PTH3R) isolated from zebrafish; vectors, host cells, recombinant methods for producing; use in identifying receptor agonists, antagonists
04/01/2003US6541217 Polypeptide for use in the treatment of cancer and hematopoietic defects
04/01/2003US6541212 Anticancer agents
04/01/2003US6541210 Viruses; bacteriophage; Hepatitis B; Hepatitis C; autoimmune disease; use to immunize an organism with a peptide that mimics an antigen or pathogenic organism specific to a disease
04/01/2003US6541209 Bioassay; identification of compounds as agonists; use in treatment of diseases and disorders that are related to 5-HT2A and or 5-HT2C serotonin receptors
04/01/2003US6541199 Identification of a new ehrlichia species from a patient suffering from ehrlichiosis
04/01/2003US6541198 Use of murine cell lines to produce monoclonal antibodies for use in diagnostic immunosassy kit for the detection of Hepatitis B virus
04/01/2003US6541020 An antiviral agent consists of a polymer material that forms a hydrogel at physiological temperatures, and a polypeptide having a specific amino acid sequence
04/01/2003US6541012 System for the production of AAV vectors
04/01/2003US6541011 A recombinant multivalent antigenic polypeptide containing a first antigenic determinant of a first polypeptide and atleast a second antigenic determinant from a second polypeptide
04/01/2003US6541010 Alphavirus RNA replicon systems
04/01/2003US6541009 Viral vaccines
04/01/2003US6541008 Vascular endothelial growth factor-like protein from orf viruses binds and activates mammalian VEGF receptor-2, and uses thereof
04/01/2003US6541007 Vaccine for Pseudomonas aeruginosa
04/01/2003US6540996 Compound screening methods
04/01/2003US6540992 Elk ligand (Elk-L) where elk is a member of the tyrosine kinase receptor family; protects against excitotoxicity, especially of the hipocammpal neurons
04/01/2003US6540977 Cyanidin compositions and therapeutic and diagnostic uses therefor
04/01/2003US6540949 Bioriented polyethylene film with a high water vapor transmission rate
04/01/2003CA2290906C Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
04/01/2003CA2245108C Tandem fluorescent protein constructs
04/01/2003CA2235951C Novel uses of mammalian ctla-8 and related reagents
04/01/2003CA2102129C Growth hormone antagonists
04/01/2003CA2101070C Antigen-presenting capsid with fusion ms2-coat protein
04/01/2003CA1341426C Process for the manufacture of thrombin inhibitors
03/2003
03/27/2003WO2003025579A2 Use of heart fatty acid binding protein
03/27/2003WO2003025572A1 Arf and hdm2 interaction domains and methods of use thereof
03/27/2003WO2003025542A2 Immune response associated proteins
03/27/2003WO2003025228A1 Methods and compositions for treating hcap associated diseases
03/27/2003WO2003025225A2 Pthr1 gene polymorphisms
03/27/2003WO2003025223A2 Improvements in or relating to insecticide screening
03/27/2003WO2003025222A1 Brain expressed cap-2 gene and protein associated with bipolar disorder
03/27/2003WO2003025220A2 Fusion proteins useful for detecting analytes
03/27/2003WO2003025218A2 Methods and yeast strains for screening antifungal agents
03/27/2003WO2003025214A1 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
03/27/2003WO2003025201A2 Methods of using 5433, a human calcium channel family member
03/27/2003WO2003025197A2 Mutant sh3-binding protein compositions and methods
03/27/2003WO2003025187A2 Improvement of gene expression in vectors
03/27/2003WO2003025186A1 Method of altering plant secondary metabolite biosynthesis in plant cells
03/27/2003WO2003025182A1 Dna for overexpression of growth hormone and utilization thereof
03/27/2003WO2003025180A1 Human cervical cancer suppressor gene and protein encoded therein
03/27/2003WO2003025179A1 Novel polypeptide, dna thereof and use of the same
03/27/2003WO2003025178A1 Novel protein and dna thereof
03/27/2003WO2003025177A2 Sequences involved in phenomena of tumour suppression, tumour reversion, adoptosis and/or resistance to viruses and the use thereof as medicaments
03/27/2003WO2003025176A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/27/2003WO2003025175A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
03/27/2003WO2003025174A2 Regulation of human mrp1-like protein
03/27/2003WO2003025171A2 Modulation of retinoic acid receptor gene expression and therapeutic uses thereof
03/27/2003WO2003025168A1 Novel protein and dna thereof
03/27/2003WO2003025167A2 Cultured stromal cells and uses thereof
03/27/2003WO2003025156A2 Methods and apparatuses for purification
03/27/2003WO2003025153A2 Enhanced proteins and methods for their use
03/27/2003WO2003025150A2 Lipid-associated molecules
03/27/2003WO2003025148A2 Novel nucleic acids and polypeptides
03/27/2003WO2003025147A2 Novel polynucleotides and proteins encoded thereby
03/27/2003WO2003025145A2 Nanomachine compositions and methods of use
03/27/2003WO2003025143A2 Maxp1
03/27/2003WO2003025142A2 Novel nucleic acids and secreted polypeptides
03/27/2003WO2003025140A2 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003WO2003025138A2 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
03/27/2003WO2003025137A2 Sweet taste receptors
03/27/2003WO2003025135A2 Genes associated with malignant neoplasms
03/27/2003WO2003025134A2 mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
03/27/2003WO2003025131A2 Protein modification and maintenance molecules
03/27/2003WO2003025130A2 Receptors and membrane-associated proteins
03/27/2003WO2003025129A2 Neurotransmission-associated proteins
03/27/2003WO2003025126A2 Compositions and methods for t cell priming and immunotherapy
03/27/2003WO2003025125A2 Selective substrates for matrix metalloproteinases
03/27/2003WO2003025121A2 Igf-binding protein-derived peptide or small molecule
03/27/2003WO2003025120A2 Clasp membrane proteins
03/27/2003WO2003025116A2 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production
03/27/2003WO2003025017A1 Cytokine receptor
03/27/2003WO2003025016A2 Trk polypeptide purification method
03/27/2003WO2003025015A2 A soluble toll-like receptor
03/27/2003WO2003025014A2 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
03/27/2003WO2003025013A1 Asparagine hydroxylation of the cad domain of a hif protein
03/27/2003WO2003025011A1 Novel peptide, novel adsorbent, adsorption unit and adsorption method
03/27/2003WO2003025010A2 Human delta-n p73 molecules and uses thereof
03/27/2003WO2003025009A1 RECOMBINANT ALLERGEN WITH REDUCED IgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY
03/27/2003WO2003025007A2 Purified polypeptides involved in membrane biosynthesis
03/27/2003WO2003025005A2 Purified bacterial polypeptides involved in protein processing
03/27/2003WO2003025004A2 Purified bacterial polypeptides involved in nucleic acid processing
03/27/2003WO2003025003A2 Hiv-gag codon-optimised dna vaccines
03/27/2003WO2003025002A2 Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection
03/27/2003WO2003025001A1 Multiple antigen peptides (map) as antidotes against snake neurotoxin intoxication
03/27/2003WO2003025000A2 Peptides capable of modulating immune response
03/27/2003WO2003024999A2 THE F-BOX PROTEIN hCdc4 TARGETS CYCLIN E FOR UBIQUITINYLATION AND DEGRADATION
03/27/2003WO2003024998A1 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen
03/27/2003WO2003024994A1 Detection and treatment of cancers of the lung
03/27/2003WO2003024992A2 HUMAN AND MOUSE β-DEFENSINS, ANTIMICROBIAL PEPTIDES
03/27/2003WO2003024991A2 Tall-1 receptor molecules and uses thereof
03/27/2003WO2003024990A2 Variants of corticotropin releasing hormone receptor type 1 and uses thereof
03/27/2003WO2003024481A2 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
03/27/2003WO2003024474A2 Anti-inflammatory agent
03/27/2003WO2003024409A2 Q4n2neg2 enhances cftr activity
03/27/2003WO2003024392A2 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003WO2003024389A2 T. reesei phytase enyzmes, polynucleides encoding the enzymes, vectors and host cells thereof, and methods of using
03/27/2003WO2003024316A2 Pore-forming agents for orthopedic cements
03/27/2003WO2003024308A2 Methods of assaying connective tissue growth factor
03/27/2003WO2003024302A2 Detection and treatment of cancers of breast
03/27/2003WO2003024276A1 A human gtp-releasing factor family member (15368) and uses therefor
1 ... 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 ... 2916